Search results
Drugs like Ozempic could protect kidney health in people with heart disease, obesity
MedicalNewsToday via AOL· 22 hours agoData from a new clinical trial suggest that people with obesity and cardiovascular disease who use...
GLP-1 Drug Semaglutide May Decrease Kidney Disease Risk
Healthline via AOL· 1 day agoNew research has found that semaglutide, a popular medication used to treat diabetes and obesity,...
Ozempic Cuts Risk of Chronic Kidney Disease Complications, Study Finds
New York Times· 2 days agoA major clinical trial showed such promising results that the drug’s maker halted it early. Dani...
Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study...
CNN via Yahoo News· 2 days agoWeekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious ...
Wegovy users have less kidney-related health problems, analysis of Novo study finds By Reuters
Investing.com· 22 hours ago"By addressing key markers of kidney health, semaglutide...may contribute to a significant reduction...
90% of U.S. Adults Have This Syndrome That Leads to Heart Disease—and Have No Clue
Prevention via AOL· 5 days agoCKM syndrome, a cluster of conditions that may lead to heart disease, may affect 90% of U.S. adults....
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 12 hours agoVera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious ...
What is CKM Syndrome? Report Finds Most Americans Meet Criteria For Early Stages
Health.com· 6 days agoAlmost 90% of Americans meet the criteria for cardiovascular-kidney-metabolic (CKM) syndrome,...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KFDX Wichita Falls· 1 day agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
KFDX Wichita Falls· 1 day ago...activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA...